ProfileGDS4718 / 212764_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 65% 77% 99% 55% 80% 53% 75% 72% 78% 67% 76% 81% 64% 73% 68% 87% 77% 80% 49% 93% 71% 76% 75% 73% 68% 73% 80% 61% 68% 34% 48% 90% 72% 70% 86% 84% 53% 81% 72% 99% 75% 73% 96% 72% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]6.470165
GSM549102patient 115, normal, homogenized [OPG study]7.4242177
GSM549104patient 119, normal, homogenized [OPG study]12.735499
GSM549108patient 138, normal, homogenized [OPG study]5.8262755
GSM549119patient 077, normal, homogenized [OPG study]7.8050580
GSM549133patient 032, cancer, homogenized [OPG study]5.6650153
GSM549139patient 042, cancer, homogenized [OPG study]7.3238875
GSM549099patient 107, normal, homogenized [OPG study]6.9904772
GSM549109patient 139, normal, homogenized [OPG study]7.6082278
GSM549110patient 046, normal, homogenized [OPG study]6.6266867
GSM549114patient 063, normal, homogenized [OPG study]7.4762476
GSM549122patient 082, normal, homogenized [OPG study]7.9489581
GSM549134patient 033, cancer, homogenized [OPG study]6.4025564
GSM549136patient 036, cancer, homogenized [OPG study]7.1848573
GSM549140patient 044, cancer, homogenized [OPG study]6.7142668
GSM549111patient 047, normal, homogenized [OPG study]8.7804987
GSM549113patient 057, normal, homogenized [OPG study]7.5615777
GSM549132patient 031, cancer, homogenized [OPG study]7.8785280
GSM549137patient 038, cancer, homogenized [OPG study]5.4358649
GSM549142patient 047, cancer, homogenized [OPG study]9.3526193
GSM549100patient 110, normal, homogenized [OPG study]6.9460771
GSM549107patient 135, normal, homogenized [OPG study]7.4192176
GSM549115patient 068, normal, homogenized [OPG study]7.3890175
GSM549116patient 072, normal, homogenized [OPG study]7.1846973
GSM549120patient 078, normal, homogenized [OPG study]6.7345468
GSM549131patient 030, cancer, homogenized [OPG study]7.210973
GSM549118patient 074, normal, homogenized [OPG study]7.867880
GSM549129patient 027, cancer, homogenized [OPG study]6.2096261
GSM549123patient 088, normal, homogenized [OPG study]6.7378868
GSM549124patient 006, cancer, homogenized [OPG study]4.7785534
GSM549126patient 015, cancer, homogenized [OPG study]5.3921548
GSM549128patient 025, cancer, homogenized [OPG study]9.1894590
GSM549103patient 117, normal, homogenized [OPG study]6.9859472
GSM549117patient 073, normal, homogenized [OPG study]6.7850570
GSM549138patient 041, cancer, homogenized [OPG study]8.6317486
GSM549141patient 045, cancer, homogenized [OPG study]8.3962384
GSM549130patient 028, cancer, homogenized [OPG study]5.7026553
GSM549101patient 111, normal, homogenized [OPG study]7.9795781
GSM549105patient 128, normal, homogenized [OPG study]7.0602872
GSM549106patient 134, normal, homogenized [OPG study]13.031499
GSM549112patient 048, normal, homogenized [OPG study]7.3686875
GSM549125patient 011, cancer, homogenized [OPG study]7.1122973
GSM549127patient 024, cancer, homogenized [OPG study]10.504596
GSM549135patient 035, cancer, homogenized [OPG study]7.1274372